ASPHD1 Human

Aspartate Beta-Hydroxylase Domain Containing 1 Human Recombinant
Cat. No.
BT25692
Source
Escherichia Coli.
Synonyms
Aspartate beta-hydroxylase domain containing 1, ASPHD1.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

ASPHD1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 318 amino acids (96-390a.a) and having a molecular mass of 33.6kDa.
ASPHD1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Aspartate Beta-Hydroxylase Domain Containing 1, also known as ASPHD1, is a member of the aspartyl/asparaginyl beta-hydroxylase family. This gene encodes the ASPHD1 protein.
Description
Recombinant human ASPHD1 protein was expressed in E. coli and purified to a single, non-glycosylated polypeptide chain. The protein contains 318 amino acids (residues 96-390) and has a molecular weight of 33.6 kDa. A 23 amino acid His-tag is present at the N-terminus. Purification was achieved using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The ASPHD1 protein is supplied in a solution at a concentration of 0.5 mg/ml. The solution contains 20 mM Tris-HCl buffer (pH 8.0), 0.4 M Urea, and 10% glycerol.
Stability
For short-term storage (up to 4 weeks), store the protein solution at 4°C. For long-term storage, freeze the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 90.0% using SDS-PAGE analysis.
Synonyms
Aspartate beta-hydroxylase domain containing 1, ASPHD1.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSYRLGSQD MQALGAGSRA GGVRGGPVGC SEAGGPSPGG PGDPGEGPRT EGLVSRRLRA YARRYSWAGM GRVRRAAQGG PGPGRGPGVL GIQRPGLLFL PDLPSAPFVP RDAQRHDVEL LESSFPAILR DFGAVSWDFS GTTPPPRGWS PPLAPGCYQL LLYQAGRCQP SNCRRCPGAY RALRGLRSFM SANTFGNAGF SVLLPGARLE GRCGPTNARV RCHLGLKIPP GCELVVGGEP QCWAEGHCLL VDDSFLHTVA HNGSPEDGPR VVFIVDLWHP NVAGAERQAL DFVFAPDP.

Product Science Overview

Introduction

Aspartate Beta-Hydroxylase Domain Containing 1 (ASPHD1) is a protein-coding gene that belongs to the aspartyl/asparaginyl beta-hydroxylase family. This gene encodes a protein that is involved in the modification of peptidyl-amino acids, specifically through its dioxygenase activity. ASPHD1 is an important paralog of aspartate beta-hydroxylase (ASPH), which is a type 2 transmembrane protein and part of the α-ketoglutarate (αKG)-dependent dioxygenases family .

Gene and Protein Structure

The ASPHD1 gene is located on chromosome 16 and is known to produce a protein that consists of 318 amino acids with a molecular mass of approximately 33.6 kDa . The protein is non-glycosylated and is produced in E. coli for recombinant purposes . The gene has several aliases, including ASPH1 and EC 1.14.11, and is associated with various pathways and disorders .

Biological Function

ASPHD1 is predicted to enable dioxygenase activity, which is crucial for the hydroxylation of aspartate residues in proteins. This modification is important for the proper functioning of various proteins and enzymes. The protein is also predicted to be an integral component of the membrane, suggesting its involvement in membrane-associated processes .

Clinical Significance

ASPHD1 has been associated with several diseases, including Autosomal Dominant Intellectual Developmental Disorder 6 and Chromosome 15Q26-Qter Deletion Syndrome . Recent studies have also indicated that ASPHD1 may play a role in cancer progression, particularly in skin cutaneous melanoma (SKCM). The expression level of ASPHD1 has been found to be significantly upregulated in several cancers, including SKCM, and is associated with patient survival . The protein’s role in the regulation of the tumor immune microenvironment and its association with immune checkpoint markers like CTLA4 and CD276 further highlight its clinical importance .

Research and Applications

The recombinant form of ASPHD1 is used in various research applications, including the study of its role in cancer and other diseases. The protein’s involvement in peptidyl-amino acid modification makes it a valuable target for understanding the mechanisms of protein function and regulation. Additionally, the study of ASPHD1’s interaction with other proteins and its role in cellular processes can provide insights into potential therapeutic targets for diseases associated with its dysregulation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.